# Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults

> **NCT02547792** · PHASE1 · COMPLETED · sponsor: **Vaxart** · enrollment: 54 (actual)

## Conditions studied

- Seasonal Influenza B

## Interventions

- **BIOLOGICAL:** VXA-BYW.10 (Low Dose) Oral Vaccine
- **BIOLOGICAL:** VXA-BYW.10 (High Dose) Oral Vaccine
- **OTHER:** Placebo Tablets

## Key facts

- **NCT ID:** NCT02547792
- **Lead sponsor:** Vaxart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-20
- **Primary completion:** 2016-11-21
- **Final completion:** 2016-11-21
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2018-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02547792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02547792, "Assessment of an Oral Influenza B Vaccine Tablet (VXA-BYW.10) Following Single Dose Administration in Healthy Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02547792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*